Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir
Open Access
- 1 November 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 155 (6) , 875-883
- https://doi.org/10.1038/bjp.2008.320
Abstract
Background and purpose: Drug efflux tranporters (P‐glycoprotein (P‐gp), multidrug resistance‐associated protein (MRP)) limit the cellular uptake of human immunodeficiency virus protease inhibitors but the contribution of influx transporters in cells that (over)express P‐gp or MRP is less clear. Here, we studied the expression of one influx transporter system, human organic anion‐transporting polypeptide (hOATP), in some T‐cell lines (CEM, CEMVBL, CEME1000) and in peripheral blood mononuclear cells (PBMCs) and examined the effects of manipulation of influx/efflux transporters on the uptake of saquinavir and lopinavir.Experimental approach: The expression of hOATPs was studied by PCR. We used hOATP substrate or inhibitor (estrone‐3‐sulphate (E‐3‐S) or montelukast, respectively) and inhibitors of P‐gp (XR9576) and MRP (MK571 and frusemide) to study functional interactions between influx and efflux transporters in the uptake of saquinavir and lopinavir. Lipophilicity of the drugs was measured by octanol/saline partition coefficient.Key results: CEM cells, their variants and PBMCs express various hOATP isoforms, with OATP3A1 detected in all of the cells. MK571, XR9576 and frusemide increased the uptake of saquinavir and lopinavir. E‐3‐S and montelukast reduced the uptake of saquinavir and lopinavir in some, but not all, of the cells. Pretreatment of the cells with MK571, XR9576 or frusemide, followed by E‐3‐S co‐incubation reduced the cellular accumulation of saquinavir and lopinavir. Lopinavir is much more lipophilic than saquinavir.Conclusions and implications: Human OATPs, MRP, P‐gp and lipophilicity determine the cellular uptake and retention of saquinavir and lopinavir. These data may have important implications for drug–drug interactions, drug safety and efficacy.British Journal of Pharmacology(2008)155, 875–883; doi:10.1038/bjp.2008.320; published online 18 August 2008Keywords
This publication has 32 references indexed in Scilit:
- Cytochrome P450 Enzymes and Transporters Induced by Anti-Human Immunodeficiency Virus Protease Inhibitors in Human Hepatocytes: Implications for Predicting Clinical Drug InteractionsDrug Metabolism and Disposition, 2007
- Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitorInternational Journal of Pharmaceutics, 2007
- Molecular Characterization and Inhibition of Amanitin Uptake into Human HepatocytesToxicological Sciences, 2006
- In Vitro Synergy and Enhanced Murine Brain Penetration of Saquinavir Coadministered with MefloquineThe Journal of Pharmacology and Experimental Therapeutics, 2005
- The intracellular pharmacology of antiretroviral protease inhibitorsJournal of Antimicrobial Chemotherapy, 2004
- Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemiaChemico-Biological Interactions, 2004
- Therapeutic Drug MonitoringDrugs, 2003
- Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- Cell volumes of normal and malignant mononuclear cells.Journal of Clinical Pathology, 1981